Exelixis (NASDAQ:EXEL) reported quarterly earnings results on February 10, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.94, beating the consensus estimate of $0.76 by $0.18 per share. Revenue came in at $598.7M, beating the estimate of $594.5M.
Exelixis's stock moved following the earnings release. The stock currently trades at $43.05 with a market capitalization of $11.1B.